Evidence-based practice of transfusion medicine: Is it possible and what do the words mean?

Transfusion Medicine Reviews

Volumn 18, Issue 4, 2004, Pages 267-278

  Vamvakas, Eleftherios C ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; LEUKOCYTE; MEDICAL PRACTICE; MEDICAL RESEARCH; REVIEW; RISK MANAGEMENT; SAFETY; STRENGTH; SYSTEMATIC REVIEW; VASCULARIZATION;

EID: 6344231577     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2004.06.003     Document Type: Article

References (56)

1. Dzik S., Aubuchon J., Jeffries L., et al. Leukocyte reduction of blood components Public policy and new technology. Transfus Med Rev. 14:2000;34-52
2. Ness P.M., Lipton K.S. Selective transfusion protocols Errors and accidents waiting to happen. Transfusion. 41:2001;713-715
3. Vamvakas E.C., Blajchman M.A. Deleterious clinical effects of transfusion-associated immunomodulation Fact or fiction? Blood. 97:2001;1180-1195
4. Vamvakas E.C., Blajchman M.A. Universal WBC reduction The case for and against. Transfusion. 41:2001;691-712
5. Collier A., Kalish L., Busch M., et al. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection. JAMA. 285:2001;1592-1601
6. van de Watering L.M.G., Hermans J., Houbiers J.G.A., et al. Beneficial effect of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery A randomized clinical trial. Circulation. 97:1998;562-568
7. Vamvakas E.C. WBC-containing allogeneic blood transfusion and mortality A meta-analysis of randomized controlled trials. Transfusion. 43:2003;963-973
8. Jensen L.S., Andersen A.J., Christiansen P.M., et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 79:1992;513-516
9. Busch O.R.C., Hop W.C.J., van Papendrecht M.A.W.H., et al. Blood transfusion and prognosis in colorectal cancer. N Engl J Med. 328:1993;1372-1376
10. Heiss M.M., Mempel W., Jausch K.-.W., et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 342:1993;1328-1333
11. Houbiers J.G.A., Brand A., van de Watering L.M.G., et al. Randomized controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 344:1994;573-578
12. Pertila J.T., Salo M.S., Jalonen J.R., et al. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune response to open-heart surgery. Anesth Analg. 79:1994;654-660
13. Jensen L.S., Kissmeyer-Nielsen P., Wolff B., et al. Randomized comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet. 34:1996;841-845
14. Newman J.H., Bowers M., Murphy J. The clinical advantages of autologous transfusion A randomized, controlled study after knee replacement. J Bone Joint Surg Br. 79:1997;630-632
15. Farrer A., Spark J.I., Scott D.J. Autologous blood transfusion The benefits for the patient undergoing abdominal aortic aneurysm repair. J Vasc Nurs. 15:1997;111-115
16. Tartter P.I., Mohandas K., Azar P., et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg. 176:1998;462-466
17. Titlestad I.L., Ebbesen L.S., Ainsworth A.P., et al. Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications Results of a double-blind, randomized study. Int J Colorectal Dis. 16:2001;147-153
18. Bilgin Y.M., van de Watering L.M.G., Eijsman L., et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation. 109:2004;2755-2760
19. Wong J.C.L., Torella F., Haynes S.L., et al. Autologous versus allogeneic transfusion in aortic surgery A multicenter randomized clinical trial. Ann Surg. 235:2002;145-151
20. Wallis J.P., Chapman C.E., Orr K.E., et al. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion. 42:2002;1127-1134
21. van Hilten J.A., van de Watering L.M.G., van Bockel J.H., et al. Effects of transfusion with red cells filtered to remove leukocytes Randomized controlled trial in patients undergoing major surgery. BMJ. 328:2004;1281-1284
22. Bracey A.W., Radovancevick R., Nussimeier N.A., et al. Leukocyte-reduced blood in open-heart surgery patients Effects on outcome. Transfusion. 42:2002;5S. (suppl, abstr)
23. Guyatt G.H. Evidence-based medicine. ACP J Club. 114:1991;A16
24. Guyatt G. Preface. Guyatt G., Rennie D. Users' Guides to the Medical Literature A Manual for Evidence-Based Clinical Practice. 2002;xiv AMA Press, Chicago, IL
25. Haynes R.B., Devereaux P.J., Guyatt G.H. Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club. 136:2002;A11
26. Evidence-Based Medicine Working Group. Evidence-based medicine A new approach to teaching the practice of medicine. JAMA. 268:1992;2420-2425
27. O'Brien B., Drummond M., Richardson W.S., et al. Moving from evidence to action. Economic analysis. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? JAMA. 277:1997;1552-1557
28. Green S.B., Byar D.P. Using observational data from registries to compare treatments The fallacy of omnimetrics. Stat Med. 3:1984;361-370
29. Stewart L.A., Parmar M.K.B. Meta-analysis of the literature or individual patient data Is there a difference? Lancet. 341:1993;418-422
30. Sackett D.L. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 95:(suppl 2):1989;2S-4S
31. Cook D.J., Guyatt G.H., Laupacis A., et al. Clinical recommendations using levels of evidence for antithrombotic agents. Chest. 108:(suppl): 1995;227S-230S
32. Vamvakas E.C. Statistical associations and cause-and-effect relationships. Evidence-Based Practice of Transfusion Medicine. 2001;21-64 AABB Press, Bethesda, MD
33. L'Abbé K.A., Detsky A.S., O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 107:1987;224-233
34. Chalmers I. The Cochrane Collaboration Preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci. 703:1993;156-165
35. United Nations Conference on Environment and Development. Earth Summit. Rio Declaration on Environment and Development, Rio de Janeiro, Brazil. 1992;. Publ. no. E.73II.A.14. Stockholm, United Nations
36. Wilson K., Wilson M., Hébert P.C., et al. The application of the precautionary principle to the blood system The Canadian blood system's vCJD donor deferral policy. Transfus Med Rev. 17:2003;89-94
37. Vamvakas E.C. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion The effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev. 16:2002;304-314
38. Vamvakas E.C. Meta-analysis of randomized controlled trials comparing the risk of postoperative infection between recipients of allogeneic and autologous blood transfusion. Vox Sang. 83:2002;339-346
39. Nielsen H.J., Hammer J.H., Kraup A.L., et al. Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn trauma. Burns. 25:1999;162-170
40. Dzik W.H., Anderson J.K., O'Neill E.M., et al. A prospective, randomized clinical trial of universal leukoreduction. Transfusion. 42:2002;1114-1122
41. Transcript of the 16th meeting of the Department of Health and Human Services FDA Blood Products Advisory Committee. September 18, 1998. Available at: http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3450t2.rtf. Accessed August 3, 2004
42. Transcript of the 13th meeting of the Department of Health and Human Services Advisory Committee on Blood Safety and Availability. January 25-26, 2001. Available at: http://www.hhs.gov/bloodsafety/transcripts/20010126.html. Accessed August 3, 2004
43. Klein H.G. A wolf in wolf's clothing Is it time to raise the bounty on the passenger leukocyte? Blood. 80:1992;1865-1868
44. Thurer R.L., Luban N.L., AuBuchon J.P., et al. Universal WBC reduction. Transfusion. 40:2002;751-752. (letter)
45. Baron J.F., Gourdin M., Bertrand M., et al. The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth Analg. 94:2002;529-537
46. Llewelyn C.A., Taylor R.S., Todd A.A., et al. The effect of universal leukoreduction on postoperative infections and length of stay in elective orthopedic and cardiac surgery. Transfusion. 44:2004;489-500
47. Blumberg N., Heal J.M., Cowles J.W., et al. Leukocyte-reduced transfusions in cardiac surgery Results of an implementation trial. Am J Clin Pathol. 118:2002;376-381
48. Hébert P.C., Fergusson D., Blajchman M.A., et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 289:2003;1941-1949
49. Fergusson D., Hébert P.C., Lee S.K., et al. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA. 289:2003;1950-1956
50. Vamvakas E.C. White-blood-cell-containing allogeneic blood transfusion, postoperative infection, and mortality: A meta-analysis of observational, "before-and-after" studies. Vox Sang. 86:2004;111-119
51. Corwin H.L., AuBuchon J.P. Is leukoreduction of blood components for everyone? JAMA. 289:2003;1993-1995
52. AuBuchon J.P., Petz L.D. Making decisions to improve transfusion safety. AuBuchon J.P., Petz L., Fink A. Policy Alternatives in Transfusion Medicine. 2001;193-226 AABB Press, Bethesda, MD
53. AuBuchon J.P., Birkmeyer J.D., Busch M.P. Safety of the blood supply in the United States Opportunities and controversies. Ann Intern Med. 127:1997;904-909
54. Goldstein B.D. The precautionary principle and scientific research are not antithetical. Environ Health Perspect. 107:1999;A594-A595
55. Passamani E. Clinical trials Are they ethical? N Engl J Med. 324:1991;1589-1591
56. Culpepper L., Gilbert T.T. Evidence and ethics. Lancet. 353:1999;829-831